The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is characterized by progressive cognitive deterioration, neuropsychological or behavioural disturbances, and eventual elementary neurological dysfunction. Changes in these domains lead to a reduced functional ability of the AD patient which results, inevitably, in an increasing dependency of the patient on their carer. Thus, a compromised quality of life for both the patient with AD and the carer ensues. The clinical deterioration in AD is produced by neurochemical deficits (involving cholinergic, noradrenergic and serotonergic systems) and histological changes (neuritic plaques, neurofibrillary tangles and neuronal death) in the brain. The abnormality in cholinergic neurotransmission, by contributing to both the cognitive impairment and possibly the behavioural disturbances of AD patients, has attracted particularly intense scientific attention. Evidence for the involvement of a cholinergic dimension to the behavioural changes of AD includes the following: the induction of AD-like behaviours in normal individuals by administration of anticholinergic drugs; the exaggeration of behavioural disturbances in AD patients by anticholinergic agents; the correlation of the distribution of cholinergic deficits of AD with regions that are relevant to the observed behaviours, i.e. the frontal and temporal regions; and the amelioration of behavioural disturbances in AD patients treated with cholinergic receptor agonists and cholinesterase inhibitors. This article reviews the increasing evidence that, in addition to their effects on the cognitive and functional domains of AD, cholinergic drugs may be considered psychotropic agents and are useful in the treatment of specific disorders with cholinergic deficits such as AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
Wilcock, G. K., Esiri, M. M., Bowen, D. M., & Smith, C. C. T. (1982) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(82)90045-4 · Cited by 553
Incontinence and Troublesome Behaviors Predict Institutionalization in Dementia
O'Donnell, B. F., Drachman, D. A., Barnes, H. J., Peterson, K. E., Swearer, J. M., & Lew, R. A. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500108 · Cited by 297
Cited by
Wilkinson, D. G., Francis, P. T., Schwam, E., & Payne-Parrish, J. (2004) · Drugs & Aging · doi:10.2165/00002512-200421070-00004 · Cited by 365
Current Pharmacotherapy for Alzheimer's Disease
Lleó, A., Greenberg, S. M., & Growdon, J. H. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131442 · Cited by 345
Mushtaq, G., Greig, N., Khan, J., & Kamal, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141023141545 · Cited by 331
Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.
Román, G. C., & Kalaria, R. N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.004 · Cited by 213
Więckowska, A., Kołaczkowski, M., Bucki, A., Godyń, J., Marcinkowska, M., Więckowski, K., Zaręba, P., Siwek, A., Kazek, G., Głuch-Lutwin, M., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.016 · Cited by 91
Metadata
- Authors
- Cummings, J. L.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-07
- Volume
- 3
- Issue
- 7
- Pages
- 21-29
- ISSN
- 1461-1457 (ISSN-L)
- OpenAlex
- W1991702492
- Cited by
- 57
- References
- 5
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease. https://app.cochat.ai/papers/10.1017/s1461145700001917
- The paper
- Cummings, J. L. (2000). The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145700001917
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.